- You can view the full Biogen Idec Ratings Report.
- Use our health care section to find sector-relevant news.
- Or find some new ideas from our top rated stocks lists.
- Find other investment ideas from our top rated ETFs lists.
Biogen will pay Forward $1.25 billion.
Biogen spinoff Bioverativ proved healthy out of the gate, jumping from an open of $40 a share to a close of $47.35.